il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

More documents

Recommendations

Info

Drummond,D.C.,o.Meyer,K'Hong,D'B.Kirpotin,andD.Papahadjopoulos.1999. "optimizing liposomes for delivery of chemotherapeutic agents to solid tumors'" P h armaco l. Rev - 5 l'.69 I -7 43' Duester,G. 1 996. "Involvement of alCohol dehydrogenase, short-chain dehydrogenase/reductase, aldehyde dehydrogenase, and cytochrome P450 in the control of retinoid signaling by activation of retinoic acid s1'nthesis'" B io chemi s trY. 3 5 :L2221 -12227' EckhofiC., M.D.Collins, and H.Nau. 1991. "Human plasma all-trans-, 13-cis- and 13- cis-4-oxoretinoic acid profiles during subchronic vitamin A supplementation: comparison to retinol and retinyl ester plasma levels." J.Nutr. I2I:70t6-1025 ' EckhoftC. and H.Nau. 1990. "Identification and quantitation of all-trans- and 13-cisretinoic acid and 13-cis-4-oxoretinoic acid in human plasma." J.Lipid Res' 3l:I445-1454. Ehrke,M.J., D.Maccubbin, K.Ryoyama,s.A.cohen, and E.Mihich' 1986' "Correlation between adriamycin-induced augmentation of interleukin 2 production and of cell-mediated cytotoxicity in mice." cancer Res. 46:54-60' Enari,M., H.Sakahira, H.Yokoyama, K.Okawa, A.Iwamatsu, and S.Nagata' 1998' "A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD." Nature. 391:43-50. Eppinger,T.M., J.Buck, and u.Hammerling. 1993. "Growth control or terminal differentiation: endogenous production and differential activities of vitamin A metabolitesinHL-60celis'''J.Exp.Med.7]8:|995-2005. Eucker,J., K.Bangero th,I.zavtski, H.Krebbel, c.zang,u.Heider, c.Jakob, E'Elstner' K.possinger, and O.Sezer. 2004. "Ligands of peroxisome proliferator-activated receptor gamma induce apoptosis in multiple myeloma." Anticancer Drugs' 15:955-960. 140
Evans,R.M. 1988. "The steroid and thyroid hormone receptor superfamily'" Science' 240:889-895' Eze,M.o. 1992. ,'Membrane fluidity, reactive oxygen species, and cell-mediated immunity: implications in nutrition and disease'" Med'Hypotheses' 37:220-224' Fantone,J.C. and P.A.Ward. 1985. "Polynorphonuclear leukocyte-mediated cell and tissue injury: oxygen metabolites and their relations to human disease'" Hum. P athol. 1 6:97 3 -97 8' Ferlini,c., c.De Angelis, R.Biselli, M.Distefano, G.Scambia, and A'Fattorossi' 1999' ,,sequence of metabolic changes during X-ray-induced apoptosís'" Exp'Cell Res' 247:160-167. Ferrans,V.J . lgTS."Overview of cardiac pathology in relation to anthracycline cardiotoxic ity ." C an c er Tr e at' Rep' 62 :9 5 5 -9 61' Ferre,P. 2004.,,The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity." Diabetes ' 53 Suppl 1:S43-S50' Feuerstein, G.z. and,P.R.Young. 2000. "Apoptosis in cardiac diseases: stress- and mito gen-activated signaling pathways. " c ar di ov as c. Res' 45 :5 60-5 69' Fiorella,P.D. and J.L.Napoli. 1991. "Expression of ceilular retinoic acid binding protein (CRABP) in Escherichia coli. Characlenzation and evidence that holo-CRABP is a substrate in retinoic acid metaboiism." J.Biol'chem' 266:16572-16579 ' Floyd,R.A' and J'M.Carn ey' t992. ''Free radical damage to protein and DNA: mechanismsinvolvedandreievantobservationsonbrainundergoingoxidative stress." Ann.Neurol. 32 Suppl:522-527 ' Foo,R.S.,K.Mani,andR.N.Kitsis.2005.''Deathbegetsfailureintheheart.''J.Clin.Invest. 1 15:565-571. t4l
Page 1 and 2:
il\VOLVEMENT OF RETII\OIC ACID II{
Page 3 and 4:
Title: AKNOWLEDGMENTS DEDICATION LI
Page 5 and 6:
IV.b.3. The uptake to peripheral ti
Page 7 and 8:
II.a. Total RAR and total RXR recep
Page 9 and 10:
ACKNO\ryLEDGMENTS I must say that m
Page 11 and 12:
DEDICATION To my toughest critic, m
Page 13 and 14:
Figure: LIST OF FIGURES Page: 1. Ch
Page 15 and 16:
30. A and B The expression of anti-
Page 17 and 18:
treated (ADR), trolox treated (TROL
Page 19 and 20:
INTRODUCTION Adriamycin, an anthrac
Page 21 and 22:
apoptosis, which will ultimately pr
Page 23 and 24:
LITERATURE REVIE\il I. Adriamycin i
Page 25 and 26:
Binding and alkylation of DNA Inter
Page 27 and 28:
myocardial inflammation which was s
Page 29 and 30:
1990; Kusuoka et al. l99l; Olson et
Page 31 and 32:
levels of antioxidant enzymes (Odom
Page 33 and 34:
causing the increased leakage of el
Page 35 and 36:
mechanisms which are involved in th
Page 37 and 38:
to protect against adriamycin-induc
Page 39 and 40:
The usage of Probucol.' Most promis
Page 41 and 42:
II. Oxidative stress II.a. Introduc
Page 43 and 44:
of a large array of cellular abnorm
Page 45 and 46:
menstruation (Kokawa et al. 1996),
Page 47 and 48:
DNA(Cohen 1997; Saikumar et al. 199
Page 49 and 50:
pathogenesis of heart failure. A nu
Page 51 and 52:
elonging to spontaneous hlpertensiv
Page 53 and 54:
AlþTrsns Retlnolc Acld fAfRAl g€
Page 55 and 56:
dehydrogenase (SDR), alcohol dehydr
Page 57 and 58:
(Bavik et a|. 1991). Soon after its
Page 59 and 60:
et al. 1994; Napoli 1996). The func
Page 61:
is achieved through its binding to
Page 64 and 65:
Retinoic acid signaling pathwaybegi
Page 66 and 67:
(Bavik et al. 1997). One of the mos
Page 68 and 69:
cells (Gaetano et ai. ZOot¡. The s
Page 70 and 71:
neuroblastoma, genn cell tumors and
Page 72 and 73:
presence of two distinctive pathway
Page 74 and 75:
cytochrome C release from mitochond
Page 76 and 77:
peroxidation (Sultana et a|.2004).
Page 78 and 79:
adipose tissue and to a lesser exte
Page 80 and 81:
such as; increased generation of re
Page 82 and 83:
physiological and pathological proc
Page 84 and 85:
Protective effects of PPAR y agonis
Page 86 and 87:
IIYPOTHESIS This study tests the hy
Page 88 and 89:
I.c.Collection of Tissues Hearts we
Page 90 and 91:
thoracotomy was performed and heart
Page 92 and 93:
Il.c.Western Blot Analvsis Western
Page 94 and 95:
green were counted as dead cells. T
Page 96 and 97:
RESULTS I.In Vivo Studies I.a.Gener
Page 101:
Lc. Retinoic acid receptors Three w
Page 108: The RAR o and PPAR-õ receptors RNA
Page 113 and 114: significantly decreased when compar
Page 116: IL b.7. RAR alPha recePtor levels T
Page 120: ILb. 3. RAR sammø recEtor levels F
Page 124: ILb. 5. RXR baa recEúor levels The
Page 129: visible staining were accounted as
Page 137 and 138: DISSCUSION I. Adriamvcin CardiomvoP
Page 139 and 140: Treatment with adriamycin has been
Page 141 and 142: High RA 1 Adriamycin I oxidative st
Page 143 and 144: study as well as in others (Kumar e
Page 145 and 146: It is reported that PPAR y receptor
Page 147 and 148: expression. These effects of trolox
Page 149 and 150: REFERENCES Abdul Hamied,T.A., D.Par
Page 151 and 152: Bashor,M.M., D.O.Toft, and F.Chytll
Page 153 and 154: distribution of PPAR-alpha, -beta,
Page 155 and 156: colbert,M.C., D.G.Hall, T.R.Kimball
Page 157: Diep,Q.N., M'El Mabrouk, J.S.Cohn,
Page 161 and 162: Ghione M. Development of Adriamycin
Page 163 and 164: Herman,E., R.Young, and S.Krop . Ig
Page 165 and 166: morphogenetic protein-2 inhibits se
Page 167 and 168: Khandoudi,N., P.Delerive, I.Berrebi
Page 169 and 170: Kusuoka,H., S.Futaki, Y.Koretsune,
Page 171 and 172: and myosin heavy chain gene express
Page 173 and 174: Mehta,J.L., B.Hu, J.Chen, and D.Li.
Page 175 and 176: Morriss-Kay,G.M. and s.J.ward. 1999
Page 177 and 178: Notario,B., M.Zamora, O.Vinas, and
Page 179 and 180: petkovich,M., N.J.Brand, A.Krust, a
Page 181 and 182: Ruberte,E., P.Dolle, P.Chambon, and
Page 183 and 184: Sharov,V.G., H.N.Sabbah, H.Shimoyam
Page 185 and 186: spiegelman,B.M. and J.s.Flier .1996
Page 187 and 188: Teebor,G.w., R.J.Boorstein, and J.c
Page 189 and 190: vanVeen,T.A.,H.V.vanRijen,R.F.V/ieg
Page 191 and 192: wi1liams,J.B. and J.L.Napoli. 1985.
Page 193 and 194: peroxisome proliferator-activated r
show all

il\VOLVEMENT OF RETII\OIC ACID II{ - MSpace at the University of ...

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?